Inhaled Molgramostim Promising for Autoimmune Pulmonary Alveolar Proteinosis: Phase 3 Trial Shows Medha Baranwal22 Aug 2025 9:15 PM ISTUSA: A phase 3 study published in the New England Journal of Medicine has highlighted encouraging results for inhaled molgramostim, a recombinant...
Beta-HPV can directly cause skin cancer in immunocompromised people, suggests research Dr. Kamal Kant Kohli1 Aug 2025 6:15 AM ISTResearchers at the National Institutes of Health (NIH) have shown for the first time that a type of human papillomavirus (HPV) commonly found on the...
Medical Bulletin 29/July/2025 Dr. Bhumika Maikhuri29 July 2025 3:00 PM ISTHere are the top medical news for the day:After How Long Is Dementia Usually Diagnosed?A new systematic review and meta-analysis published in the...
Mass Ivermectin Distribution Significantly Reduces Malaria Transmission: Study Finds Dr. Bhumika Maikhuri29 July 2025 8:30 AM ISTA major international study published in The New England Journal of Medicine has found that administering ivermectin to entire populations can...
New research supports Ivermectin as an effective strategy to control malaria transmission Dr. Kamal Kant Kohli28 July 2025 8:30 AM ISTIvermectin administered to the whole population significantly reduces malaria transmission, offering new hope in the fight against the disease. The...
Once-Monthly MariTide Shows Promising Weight Loss in Obesity and Type 2 Diabetes: Phase 2 Trial Medha Baranwal27 Jun 2025 9:00 AM ISTUSA: A once-monthly injectable therapy, maridebart cafraglutide (MariTide), demonstrated significant weight loss in individuals with obesity-with and...
New pulmonary arterial hypertension treatment offers hope for patients in advanced stage of disease: NEJM Dr. Prem Aggarwal12 Jun 2025 8:15 PM ISTA relatively new therapy used to treat pulmonary arterial hypertension in those with mild to moderate disease was found to be effective at preventing...
Antibiotic Prophylaxis During Pregnancy Shows No Significant Benefit on Birth Weight: Trial Shows Medha Baranwal11 Jun 2025 8:15 PM ISTZimbabwe: A widely used antibiotic combination, trimethoprim-sulfamethoxazole, did not significantly improve birth weight in infants when administered...
Simultaneous treatment start with Finerenone and SGLT-2-inhibitor demonstrated positive data in patients with CKD associated with type 2 diabetes: Bayer Ruchika Sharma9 Jun 2025 10:00 AM ISTBerlin: Bayer has announced results of the Phase II CONFIDENCE study, demonstrating that simultaneous initiation of finerenone (Kerendia)...
Medical Bulletin 9/June/2025 Dr. Bhumika Maikhuri9 Jun 2025 9:00 AM ISTHere are the top medical bulletins for the day:Trial Shows Low Cost Antibiotic Use May Reduce Preterm Births in Women with HIVA new study published in...
Trial Shows Low Cost Antibiotic Use May Reduce Preterm Births in Women with HIV Dr. Bhumika Maikhuri9 Jun 2025 8:00 AM ISTA new study published in the New England Journal of Medicine has found that a commonly used, low-cost antibiotic may significantly reduce the risk of...
Finerenone and Empagliflozin Combo Significantly Reduces Albuminuria in CKD with T2D: new data from CONFIDENCE Trial Dr. Kamal Kant Kohli6 Jun 2025 9:00 PM ISTNew findings from the CONFIDENCE trial show that combination therapy with finerenone and empagliflozin leads to significantly greater reductions in...
